Green Synthesis of Gold Nanoparticles (AuNPs) As Potential Drug Carrier for Treatment and Care of Cardiac Hypertrophy Agents

Owing to their autocatalytic properties, gold nanoparticles (AuNPs) are used in biomedical applications. While their usage in neurodegenerative disease control, diabetes, etc. has been documented, their function is mostly untapped in cardiovascular disease treatment. Hence, in this work is the leading to combine, classify and test cardiomyoblast hypertrophy efficiency of AuNPs. In the case of AuNPs, the Imperata cylindrica extracts (IPC) and gold solution (HAuCl4) were fabricated with 1:5 volume ratios and were distinguished by specific processes, such as ultraviolet–visible (UV–vis) spectroscopy, scanning electron microscopy (SEM) and high resolution transmission electron microscopy (HRTEM). The radical scavenging of superoxide and hydroxylic AuNPs has been shown to be stronger relative to bulk gold and extracts. In cell line tests, rat cardiomyoblasts H9c2 and 3T3 fluorescence were used in this work. The generation of intracellular superoxide anion was less due to the incubation of greater AuNPs levels. In addition, preliminary findings gave an insight into the role of AuNPs in attenuating cardiomyoblastic induced isoproterenol hypertrophy.